The Relation of Anxiety and Cognition in Parkinson’s Disease

Objective: Parkinson’s disease (PD) has long been conceptualized as a motor disorder, but nonmotor symptoms also manifest in the disease and significantly reduce quality of life. Anxiety and cognitive dysfunction are prevalent nonmotor symptoms, even in early disease stages, but the relation between these symptoms remains poorly understood. We examined self-reported anxiety and neurocognitive function, indexed by measures of executive function (set-shifting and phonemic fluency), categorical fluency, and attention/working memory. We hypothesized that anxiety would correlate with cognitive performance. Method: The Beck Anxiety Inventory and cognitive tests (Trail Making, Verbal Fluency, Digit Span) were administered to 77 nondemented adults with mild to moderate idiopathic PD (39 men, 38 women; Mage = 62.9 years). Results: Higher anxiety was associated with more advanced disease stage and severity and with poorer set-shifting when using a derived metric to account for motoric slowing. Depression correlated with greater anxiety and disease severity, but not with cognitive performance. Conclusions: Our findings support the association of anxiety with a specific domain of executive function, set-shifting, in nondemented individuals with mild to moderate PD, raising the possibility that treatment of anxiety may alleviate aspects of executive dysfunction in this population.

[1]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[2]  A. Cronin-Golomb,et al.  Impact of Anxiety on Quality of Life in Parkinson's Disease , 2011, Parkinson's disease.

[3]  R. Barker,et al.  Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.

[4]  B. Pollock,et al.  Comorbid anxiety disorder in late life depression: association with memory decline over four years , 2005, International journal of geriatric psychiatry.

[5]  L. Friberg,et al.  Cognitive impairment in early‐stage non‐demented Parkinson's disease patients , 2014, Acta neurologica Scandinavica.

[6]  R C Grace,et al.  A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. , 2008, Parkinsonism & related disorders.

[7]  M. Millan,et al.  The neurobiology and control of anxious states , 2003, Progress in Neurobiology.

[8]  K. Marder,et al.  Memory and executive function impairment predict dementia in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[9]  N. Narayanan,et al.  Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease , 2013, Reviews in the neurosciences.

[10]  H. Braak,et al.  Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  A. Cronin-Golomb Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease. , 2013, Behavioral neuroscience.

[12]  D. Aarsland,et al.  Mild Cognitive Impairment in Parkinson’s Disease , 2011, Current neurology and neuroscience reports.

[13]  T. Robbins,et al.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.

[14]  K. Dujardin,et al.  The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale , 2014, Movement disorders : official journal of the Movement Disorder Society.

[15]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[16]  D. Aarsland,et al.  Neuropsychiatric Symptoms in Parkinson's Disease. , 2015, Journal of Parkinson's disease.

[17]  Q. Almeida,et al.  Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory–perceptual processing while walking , 2015, Neuropsychologia.

[18]  J. Wetherell,et al.  Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  K. Dujardin,et al.  Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[20]  M. Schwarzbold,et al.  Anxiety in Parkinson’s disease: A critical review of experimental and clinical studies , 2012, Neuropharmacology.

[21]  Mariusz S Wiglusz,et al.  Prevalence of anxiety disorders in epilepsy , 2018, Epilepsy & Behavior.

[22]  J. Galvin Cognitive Change in Parkinson Disease , 2006, Alzheimer disease and associated disorders.

[23]  Maria Larsson,et al.  Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. , 2005, Journal of psychiatric research.

[24]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[25]  H. Mayberg,et al.  A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[26]  P. Martínez-Martín,et al.  Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease. , 2008, Parkinsonism & related disorders.

[27]  M. Ceccaldi,et al.  Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.

[28]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[29]  K. Walsh,et al.  Parkinson's disease and anxiety , 2001, Postgraduate medical journal.

[30]  P. Silburn,et al.  Anxiety disorders in Parkinson's disease: Prevalence and risk factors , 2010, Movement disorders : official journal of the Movement Disorder Society.

[31]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[32]  L. Fratiglioni,et al.  Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross‐sectional study , 2003, Acta neurologica Scandinavica. Supplementum.

[33]  P. Rabins,et al.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[34]  J. Obeso,et al.  Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.

[35]  S. Lewis,et al.  Anxiety is associated with freezing of gait and attentional set-shifting in Parkinson's disease: A new perspective for early intervention. , 2016, Gait & posture.

[36]  Jane S. Paulsen,et al.  The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance , 2011, Journal of clinical and experimental neuropsychology.

[37]  A. Tröster,et al.  Which symptoms of anxiety diminish after surgical interventions for Parkinson disease? , 1999, Neuropsychiatry, neuropsychology, and behavioral neurology.

[38]  M. Eysenck,et al.  Anxiety and cognitive performance: attentional control theory. , 2007, Emotion.

[39]  Megan M. Risi,et al.  Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease. , 2013, Behavioral neuroscience.

[40]  C. Stern,et al.  The Basal Ganglia and Decision-Making in Neuropsychiatric Disorders , 2016 .

[41]  R. O'Hara,et al.  The association of anxiety and depressive symptoms with cognitive performance in community-dwelling older adults. , 2009, Psychology and aging.

[42]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[43]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[44]  K. Dujardin,et al.  Anxiety rating scales in Parkinson's disease: A validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale , 2011, Movement disorders : official journal of the Movement Disorder Society.

[45]  B. Mulsant,et al.  Cognitive impairment in late-life generalized anxiety disorder. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[46]  T. Tombaugh Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[47]  D. Aarsland,et al.  A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[48]  K. Bayles,et al.  A longitudinal study of neuropsychological change in individuals with Parkinson's disease , 2003, International journal of geriatric psychiatry.

[49]  M. Eysenck,et al.  Anxiety, Processing Efficiency, and Cognitive Performance New Developments from Attentional Control Theory , 2009 .

[50]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[51]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[52]  R. Brown,et al.  Apathy in Parkinson’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[53]  C. Adler,et al.  The neurobiological basis of cognitive impairment in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[54]  U. Bonuccelli,et al.  Affective symptoms and cognitive functions in Parkinson's disease , 2012, Journal of the Neurological Sciences.

[55]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[56]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[57]  M. Butters,et al.  Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder , 2011, British Journal of Psychiatry.

[58]  C. Tanner,et al.  Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. , 2009, Parkinsonism & related disorders.

[59]  Richard Mayeux,et al.  Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.

[60]  A. Cronin-Golomb,et al.  Neurocognitive Correlates of Apathy and Anxiety in Parkinson's Disease , 2011, Parkinson's disease.

[61]  N. S. Miller,et al.  Psychiatric Comorbidity , 1994, Alcohol health and research world.

[62]  P. Barone,et al.  Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia , 2009, Journal of Neurology.

[63]  I. Daum,et al.  Depressed mood and executive dysfunction in early Parkinson's disease , 2003, Acta neurologica Scandinavica.

[64]  S. Papapetropoulos,et al.  Psychiatric comorbidity in a population of Parkinson's disease patients , 2006, European journal of neurology.

[65]  A. Cronin-Golomb,et al.  Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson's Disease , 2012, Parkinson's disease.

[66]  R. L. Greene,et al.  Changes in neuropsychological functioning in an aging population. , 1980, Journal of consulting and clinical psychology.

[67]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[68]  G. Ganis,et al.  Frontostriatal circuits are necessary for visuomotor transformation: Mental rotation in Parkinson's disease , 2006, Neuropsychologia.

[69]  J. Groothoff,et al.  The impact of sleep and mood disorders on quality of life in Parkinson’s disease patients , 2011, Journal of Neurology.

[70]  Angie A. Kehagia,et al.  Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation , 2010, Current Opinion in Neurobiology.

[71]  Manuel Rodríguez,et al.  The basal ganglia and disorders of movement: pathophysiological mechanisms. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[72]  Daniel Weintraub,et al.  Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. , 2009, Parkinsonism & related disorders.

[73]  M. Jahanshahi,et al.  Executive dysfunction in Parkinson's disease: a review. , 2013, Journal of neuropsychology.

[74]  A. Cronin-Golomb,et al.  Alexithymia and Apathy in Parkinson’s Disease: Neurocognitive Correlates , 2013, Behavioural neurology.

[75]  W. Weiner,et al.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.

[76]  W. Weiner,et al.  Comorbidity of the nonmotor symptoms of Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[77]  A. Cronin-Golomb,et al.  The impact of motor symptoms on self-reported anxiety in Parkinson's disease. , 2017, Parkinsonism & related disorders.

[78]  Stephanie L. Alberico,et al.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease. , 2015, Basal ganglia.

[79]  D R Rajput,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[80]  Roshan Cools,et al.  Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease , 2009, Neuropsychologia.

[81]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[82]  P. Werner,et al.  Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline , 2003, International journal of geriatric psychiatry.

[83]  Matthew A. Menza,et al.  Parkinson's disease and anxiety: Comorbidity with depression , 1993, Biological Psychiatry.

[84]  K. Dujardin,et al.  Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[85]  Katherine J. Jones,et al.  Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease , 2013, Dementia and Geriatric Cognitive Disorders Extra.